Will the milestones be hit?So one single week left in the month of April and then the countdown to checking off milestones by the end of May begins. Any bets on what and what they won't check off the list? I'm hoping they don't drop a PP or further dilution out of the blue but I've learned to expect nothing, everything and anything from SBM over the years.
Check...check....check it out - the May milestones:
-Finalize due diligence and agree on terms with new organization
-Complete an additional licensing agreement for the SGLT2 inhibitor in new markets
-Secure non-dilutive funding through anticipated collaborations
-Finalize Tinyi agreement
-Complete Phase I clinical trial in China for the SGLT2 Inhibitor and advance to Phase II
-Complete safety studies and enter clinical trial for anti-wrinkle compound
-Develop new anti-viral compounds and advance them into preclinical studies